These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 26865509)
1. Dihydroartemisinin prevents liver fibrosis in bile duct ligated rats by inducing hepatic stellate cell apoptosis through modulating the PI3K/Akt pathway. Chen Q; Chen L; Wu X; Zhang F; Jin H; Lu C; Shao J; Kong D; Wu L; Zheng S IUBMB Life; 2016 Mar; 68(3):220-31. PubMed ID: 26865509 [TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin alleviates bile duct ligation-induced liver fibrosis and hepatic stellate cell activation by interfering with the PDGF-βR/ERK signaling pathway. Chen Q; Chen L; Kong D; Shao J; Wu L; Zheng S Int Immunopharmacol; 2016 May; 34():250-258. PubMed ID: 27038258 [TBL] [Abstract][Full Text] [Related]
3. Tetramethylpyrazine inhibits angiotensin II-induced activation of hepatic stellate cells associated with interference of platelet-derived growth factor β receptor pathways. Zhang X; Zhang F; Kong D; Wu X; Lian N; Chen L; Lu Y; Zheng S FEBS J; 2014 Jun; 281(12):2754-68. PubMed ID: 24725506 [TBL] [Abstract][Full Text] [Related]
4. Tetramethylpyrazine reduces glucose and insulin-induced activation of hepatic stellate cells by inhibiting insulin receptor-mediated PI3K/AKT and ERK pathways. Zhang F; Zhang Z; Kong D; Zhang X; Chen L; Zhu X; Lu Y; Zheng S Mol Cell Endocrinol; 2014 Jan; 382(1):197-204. PubMed ID: 24071517 [TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction. Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916 [TBL] [Abstract][Full Text] [Related]
6. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway. Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428 [TBL] [Abstract][Full Text] [Related]
7. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways. Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634 [TBL] [Abstract][Full Text] [Related]
8. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway. Wang J; Chu ES; Chen HY; Man K; Go MY; Huang XR; Lan HY; Sung JJ; Yu J Oncotarget; 2015 Mar; 6(9):7325-38. PubMed ID: 25356754 [TBL] [Abstract][Full Text] [Related]
9. IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway. Huang TJ; Ren JJ; Zhang QQ; Kong YY; Zhang HY; Guo XH; Fan HQ; Liu LX Biomed Pharmacother; 2019 Aug; 116():109034. PubMed ID: 31152924 [TBL] [Abstract][Full Text] [Related]
10. ROS-JNK1/2-dependent activation of autophagy is required for the induction of anti-inflammatory effect of dihydroartemisinin in liver fibrosis. Zhang Z; Guo M; Zhao S; Shao J; Zheng S Free Radic Biol Med; 2016 Dec; 101():272-283. PubMed ID: 27989749 [TBL] [Abstract][Full Text] [Related]
11. Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism. Xu W; Lu C; Zhang F; Shao J; Zheng S IUBMB Life; 2016 May; 68(5):376-87. PubMed ID: 27027402 [TBL] [Abstract][Full Text] [Related]
12. The Salvia miltiorrhiza monomer IH764-3 induces apoptosis of hepatic stellate cells in vivo in a bile duct ligation-induced model of liver fibrosis. Liu L; Wei J; Huo X; Fang S; Yao D; Gao J; Jiang H; Zhang X Mol Med Rep; 2012 Dec; 6(6):1231-8. PubMed ID: 22971838 [TBL] [Abstract][Full Text] [Related]
13. Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of κB kinase α/inhibitor of κB-α/nuclear factor-κB pathway. Ping J; Gao AM; Qin HQ; Wei XN; Bai J; Liu L; Li XH; Li RW; Ao Y; Wang H J Pharmacol Exp Ther; 2011 Nov; 339(2):694-703. PubMed ID: 21862660 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis. Son G; Hines IN; Lindquist J; Schrum LW; Rippe RA Hepatology; 2009 Nov; 50(5):1512-23. PubMed ID: 19790269 [TBL] [Abstract][Full Text] [Related]
15. Dihydroartemisinin alleviates hepatic fibrosis through inducing ferroptosis in hepatic stellate cells. Zhang Z; Wang X; Wang Z; Zhang Z; Cao Y; Wei Z; Shao J; Chen A; Zhang F; Zheng S Biofactors; 2021 Sep; 47(5):801-818. PubMed ID: 34129254 [TBL] [Abstract][Full Text] [Related]
16. Dong Z; Guan H; Wang L; Liang L; Zang Y; Wu L; Bao L Mol Med Rep; 2024 Nov; 30(5):. PubMed ID: 39219289 [TBL] [Abstract][Full Text] [Related]
17. Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis. Zhang Z; Yao Z; Zhao S; Shao J; Chen A; Zhang F; Zheng S Cell Death Dis; 2017 Jun; 8(6):e2886. PubMed ID: 28617435 [TBL] [Abstract][Full Text] [Related]
18. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats. Eissa LA; Kenawy HI; El-Karef A; Elsherbiny NM; El-Mihi KA Chem Biol Interact; 2018 Oct; 294():91-100. PubMed ID: 30138605 [TBL] [Abstract][Full Text] [Related]
19. SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin α5β1/PI3K/Akt signaling pathway. Du Z; Lin Z; Wang Z; Liu D; Tian D; Xia L Lab Invest; 2020 Aug; 100(8):1042-1056. PubMed ID: 32291390 [TBL] [Abstract][Full Text] [Related]
20. Microvesicles Derived from TGF-β1 Stimulated Hepatic Stellate Cells Aggravate Hepatocellular Injury. Liang Y; Pan Q; Wang R; Ye Z; Li Z; Zeng L; Chen Y; Ma X; Li M; Miao H Stem Cells Dev; 2019 Aug; 28(16):1128-1139. PubMed ID: 31140359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]